Global and Region Generic Medicine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Generic Medicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Generic Medicinemarket, defines the market attractiveness level of Generic Medicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Generic Medicine industry, describes the types of Generic Medicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Generic Medicine market and the development prospects and opportunities of Generic Medicine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Generic Medicine market in Chapter 13.

    By Player:

    • Apotex

    • Sun Pharmaceutical

    • Aspen

    • Sanofi

    • ENDO (Par Pharmaceutical)

    • Pfizer (Hospira)

    • Mylan

    • Zydus Cadila

    • Novartis - Sandoz

    • Teva

    • Stada Arzneimittel

    • Nichi-Iko Pharmaceutical

    • Lupin

    • Krka Group

    • Aurobindo

    • Fresenius Kabi

    • Dr Reddy's

    • Cipla

    • Hikma

    • Valeant

    By Type:

    • Simple Generic Drugs

    • Super Generic Drugs

    • Biosimilars

    • By Application:

    • CNS

    • Cardiovascular

    • Respiratory

    • Rheumatology

    • Diabetes

    • Oncology

    By End-User:

    • CNS

    • Cardiovascular

    • Respiratory

    • Rheumatology

    • Diabetes

    • Oncology

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Generic Medicine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Generic Medicine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Generic Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Generic Medicine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Generic Medicine Market Analysis and Outlook to 2022

    • 7.1 Global Generic Medicine Consumption (2017-2022)

    • 7.2 United States Generic Medicine Consumption (2017-2022)

    • 7.3 Europe Generic Medicine Consumption (2017-2022)

    • 7.4 China Generic Medicine Consumption (2017-2022)

    • 7.5 Japan Generic Medicine Consumption (2017-2022)

    • 7.6 India Generic Medicine Consumption (2017-2022)

    • 7.7 South Korea Generic Medicine Consumption (2017-2022)

    8 Region and Country-wise Generic Medicine Market Analysis and Outlook to 2028

    • 8.1 Global Generic Medicine Consumption Forecast (2022-2028)

    • 8.2 United States Generic Medicine Consumption Forecast (2022-2028)

    • 8.3 Europe Generic Medicine Consumption Forecast (2022-2028)

    • 8.4 China Generic Medicine Consumption Forecast (2022-2028)

    • 8.5 Japan Generic Medicine Consumption Forecast (2022-2028)

    • 8.6 India Generic Medicine Consumption Forecast (2022-2028)

    • 8.7 South Korea Generic Medicine Consumption Forecast (2022-2028)

    9 Global Generic Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Generic Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Simple Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Super Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Biosimilars Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global By Application: Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global CNS Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Respiratory Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Rheumatology Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Oncology Consumption and Growth Rate (2017-2022)

    • 9.2 Global Generic Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global CNS Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Respiratory Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Rheumatology Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Generic Medicine Market Outlook by Types and Applications to 2028

    • 10.1 Global Generic Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Simple Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Super Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global By Application: Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global CNS Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Generic Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global CNS Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Generic Medicine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Generic Medicine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Generic Medicine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Generic Medicine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Generic Medicine Market Competitive Analysis

    • 14.1 Apotex

      • 14.1.1 Apotex Company Details

      • 14.1.2 Apotex Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Apotex Generic Medicine Product and Service

    • 14.2 Sun Pharmaceutical

      • 14.2.1 Sun Pharmaceutical Company Details

      • 14.2.2 Sun Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sun Pharmaceutical Generic Medicine Product and Service

    • 14.3 Aspen

      • 14.3.1 Aspen Company Details

      • 14.3.2 Aspen Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aspen Generic Medicine Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Generic Medicine Product and Service

    • 14.5 ENDO (Par Pharmaceutical)

      • 14.5.1 ENDO (Par Pharmaceutical) Company Details

      • 14.5.2 ENDO (Par Pharmaceutical) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 ENDO (Par Pharmaceutical) Generic Medicine Product and Service

    • 14.6 Pfizer (Hospira)

      • 14.6.1 Pfizer (Hospira) Company Details

      • 14.6.2 Pfizer (Hospira) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer (Hospira) Generic Medicine Product and Service

    • 14.7 Mylan

      • 14.7.1 Mylan Company Details

      • 14.7.2 Mylan Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Mylan Generic Medicine Product and Service

    • 14.8 Zydus Cadila

      • 14.8.1 Zydus Cadila Company Details

      • 14.8.2 Zydus Cadila Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Zydus Cadila Generic Medicine Product and Service

    • 14.9 Novartis - Sandoz

      • 14.9.1 Novartis - Sandoz Company Details

      • 14.9.2 Novartis - Sandoz Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis - Sandoz Generic Medicine Product and Service

    • 14.10 Teva

      • 14.10.1 Teva Company Details

      • 14.10.2 Teva Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Generic Medicine Product and Service

    • 14.11 Stada Arzneimittel

      • 14.11.1 Stada Arzneimittel Company Details

      • 14.11.2 Stada Arzneimittel Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Stada Arzneimittel Generic Medicine Product and Service

    • 14.12 Nichi-Iko Pharmaceutical

      • 14.12.1 Nichi-Iko Pharmaceutical Company Details

      • 14.12.2 Nichi-Iko Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Nichi-Iko Pharmaceutical Generic Medicine Product and Service

    • 14.13 Lupin

      • 14.13.1 Lupin Company Details

      • 14.13.2 Lupin Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Lupin Generic Medicine Product and Service

    • 14.14 Krka Group

      • 14.14.1 Krka Group Company Details

      • 14.14.2 Krka Group Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Krka Group Generic Medicine Product and Service

    • 14.15 Aurobindo

      • 14.15.1 Aurobindo Company Details

      • 14.15.2 Aurobindo Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Aurobindo Generic Medicine Product and Service

    • 14.16 Fresenius Kabi

      • 14.16.1 Fresenius Kabi Company Details

      • 14.16.2 Fresenius Kabi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Fresenius Kabi Generic Medicine Product and Service

    • 14.17 Dr Reddy's

      • 14.17.1 Dr Reddy's Company Details

      • 14.17.2 Dr Reddy's Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Dr Reddy's Generic Medicine Product and Service

    • 14.18 Cipla

      • 14.18.1 Cipla Company Details

      • 14.18.2 Cipla Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Cipla Generic Medicine Product and Service

    • 14.19 Hikma

      • 14.19.1 Hikma Company Details

      • 14.19.2 Hikma Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Hikma Generic Medicine Product and Service

    • 14.20 Valeant

      • 14.20.1 Valeant Company Details

      • 14.20.2 Valeant Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Valeant Generic Medicine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Generic Medicine

    • Figure Generic Medicine Picture

    • Table Global Generic Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Medicine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Generic Medicine Consumption by Country (2017-2022)

    • Figure United States Generic Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe Generic Medicine Consumption and Growth Rate (2017-2022)

    • Figure China Generic Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Generic Medicine Consumption and Growth Rate (2017-2022)

    • Figure India Generic Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Generic Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Generic Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Simple Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Super Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global By Application: Consumption and Growth Rate (2017-2022)

    • Figure Global CNS Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Consumption and Growth Rate (2017-2022)

    • Figure Global Rheumatology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global CNS Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Consumption and Growth Rate (2017-2022)

    • Figure Global Rheumatology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Simple Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Super Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global By Application: Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CNS Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CNS Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Generic Medicine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Generic Medicine Export by Region (Top 5 Countries) (2017-2028)

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Generic Medicine Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Generic Medicine Product and Service

    • Table Aspen (Foundation Year, Company Profile and etc.)

    • Table Aspen Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aspen Generic Medicine Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Generic Medicine Product and Service

    • Table ENDO (Par Pharmaceutical) (Foundation Year, Company Profile and etc.)

    • Table ENDO (Par Pharmaceutical) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table ENDO (Par Pharmaceutical) Generic Medicine Product and Service

    • Table Pfizer (Hospira) (Foundation Year, Company Profile and etc.)

    • Table Pfizer (Hospira) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer (Hospira) Generic Medicine Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Generic Medicine Product and Service

    • Table Zydus Cadila (Foundation Year, Company Profile and etc.)

    • Table Zydus Cadila Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zydus Cadila Generic Medicine Product and Service

    • Table Novartis - Sandoz (Foundation Year, Company Profile and etc.)

    • Table Novartis - Sandoz Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis - Sandoz Generic Medicine Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Generic Medicine Product and Service

    • Table Stada Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel Generic Medicine Product and Service

    • Table Nichi-Iko Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Nichi-Iko Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nichi-Iko Pharmaceutical Generic Medicine Product and Service

    • Table Lupin (Foundation Year, Company Profile and etc.)

    • Table Lupin Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Generic Medicine Product and Service

    • Table Krka Group (Foundation Year, Company Profile and etc.)

    • Table Krka Group Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Krka Group Generic Medicine Product and Service

    • Table Aurobindo (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Generic Medicine Product and Service

    • Table Fresenius Kabi (Foundation Year, Company Profile and etc.)

    • Table Fresenius Kabi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi Generic Medicine Product and Service

    • Table Dr Reddy's (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Generic Medicine Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Generic Medicine Product and Service

    • Table Hikma (Foundation Year, Company Profile and etc.)

    • Table Hikma Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Generic Medicine Product and Service

    • Table Valeant (Foundation Year, Company Profile and etc.)

    • Table Valeant Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Generic Medicine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.